Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Geron Corp (GERN)

Geron Corp (GERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 GlobeNewswire - Wed Apr 22, 6:00AM CDT

FOSTER CITY, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5000 (unch)
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Apr 20, 3:05PM CDT

FOSTER CITY, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective April 17, 2026, it granted stock...

GERN : 1.5000 (unch)
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Apr 14, 3:05PM CDT

FOSTER CITY, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a...

GERN : 1.5000 (unch)
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary GlobeNewswire - Mon Apr 13, 7:00AM CDT

FOSTER CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5000 (unch)
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference GlobeNewswire - Mon Apr 6, 7:00AM CDT

FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5000 (unch)
Geron Announces Appointment of New Members to its Board of Directors GlobeNewswire - Thu Mar 26, 7:00AM CDT

FOSTER CITY, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

GERN : 1.5000 (unch)
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Mar 18, 3:05PM CDT

FOSTER CITY, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective March 17, 2026, it granted stock...

GERN : 1.5000 (unch)
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone FinancialNewsMedia - Tue Mar 3, 8:00AM CST

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:NTLA),(NASDAQ:NAGE),(NASDAQ:OCGN) EQNX::TICKER_END

AVAI : 0.3100 (+1.64%)
NAGE : 4.93 (+4.23%)
GERN : 1.5000 (unch)
NTLA : 13.63 (-14.11%)
OCGN : 1.6600 (-0.60%)
Geron: Q4 Earnings Snapshot AP - Wed Feb 25, 6:28AM CST

Geron: Q4 Earnings Snapshot

GERN : 1.5000 (unch)
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights GlobeNewswire - Wed Feb 25, 6:00AM CST

Achieved $48 million and $184 million in RYTELO ® (imetelstat) net product revenue in Q4 2025 and full year 2025, respectively Reported total operating expenses of $255 million for full year 2025,...

GERN : 1.5000 (unch)

Barchart Exclusives

3 Under-the-Radar Dividend Stocks Yielding Up to 13% That Wall Street Rates a Strong Buy Barchart - Fri Apr 24, 6:00PM CDT
Three under-the-radar dividend stocks offer yields up to 13%, bullish analyst ratings, and possible upside for income investors seeking overlooked names. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.